Arcturus Therapeutics Holdings Inc (ARCT)

Apr 04, 2026

Responsive Playbooks and the ARCT Inflection - Stock Traders Daily

Apr 04, 2026

Apr 02, 2026

Hennion & Walsh Asset Management Inc. Purchases 161,910 Shares of Arcturus Therapeutics Holdings Inc. $ARCT - marketbeat.com

Apr 02, 2026

Apr 02, 2026

ARCT Stock Price, Quote & Chart | ARCTURUS THERAPEUTICS HOLDIN (NASDAQ:ARCT) - ChartMill

Apr 02, 2026

Apr 01, 2026

ARCT SEC FilingsArcturus Therape 10-K, 10-Q, 8-K Forms - Stock Titan

Apr 01, 2026

Apr 01, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Share Price Passes Below 200 Day Moving AverageShould You Sell? - marketbeat.com

Apr 01, 2026

Mar 30, 2026

Arcturus Therapeutics features Chief Medical Officer in The Bonnell Foundation podcast discussion - Traders Union

Mar 30, 2026

Mar 30, 2026

Arcturus Therapeutics Holdings (ARCT) price target decreased by 27.17% to 25.78 - msn.com

Mar 30, 2026

Mar 29, 2026

BTIG Maintains Arcturus Therapeutics Holdings (ARCT) Buy Recommendation - msn.com

Mar 29, 2026

Mar 27, 2026

Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics By Investing.com - Investing.com South Africa

Mar 27, 2026

Mar 27, 2026

Cathie Wood’s ARK sells Nvidia stock, buys Arcturus Therapeutics - Investing.com

Mar 27, 2026

Mar 26, 2026

ARCT.O - Reuters

Mar 26, 2026

Mar 26, 2026

Roth MKM Maintains Arcturus Therapeutics(ARCT.US) With Buy Rating, Maintains Target Price $20 - Moomoo

Mar 26, 2026

Mar 26, 2026

Vanguard disaggregates holdings; reports 0 shares — Arcturus (ARCT) - Stock Titan

Mar 26, 2026

Mar 26, 2026

New Highs: Is Arcturus Therapeutics Holdings Inc forming a breakout pattern2026 Historical Comparison & Accurate Buy Signal Notifications - baoquankhu1.vn

Mar 26, 2026

Mar 26, 2026

Aug Setups: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesMarket Activity Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn

Mar 26, 2026

Mar 24, 2026

Understanding the Setup: (ARCT) and Scalable Risk - Stock Traders Daily

Mar 24, 2026

Mar 23, 2026

Arcturus Therapeutics Refocuses on Rare Disease mRNA Pipeline After COVID Vaccine Success at ROTH Conf - MarketBeat

Mar 23, 2026

Mar 23, 2026

Arcturus Therapeutics at the 38th Annual Roth Conference: Strategic Shift to Rare Diseases - Investing.com Canada

Mar 23, 2026

Mar 23, 2026

These Are the Only 3 Stocks That Cathie Wood Bought Last Week - The Motley Fool

Mar 23, 2026

Mar 23, 2026

Arcturus Therapeutics stock plunges 50% after weak cystic fibrosis trial data - MSN

Mar 23, 2026

Mar 21, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Q4 2025 earnings call transcript - MSN

Mar 21, 2026

Mar 20, 2026

This Rubrik Analyst Begins Coverage On A Bullish Note; Here Are Top 4 Initiations For Friday - Benzinga

Mar 20, 2026

Mar 20, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Stock Rating Upgraded by B. Riley Financial - marketbeat.com

Mar 20, 2026

Mar 20, 2026

This BP Analyst Is No Longer Bearish; Here Are Top 4 Upgrades For Friday - Benzinga

Mar 20, 2026

Mar 20, 2026

Arcturus Therapeutics Holdings Inc. (NASDAQ:ARCT) Receives Average Recommendation of "Moderate Buy" from Analysts - marketbeat.com

Mar 20, 2026

Mar 19, 2026

This Xponential Fitness Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Thursday - Benzinga

Mar 19, 2026

Mar 19, 2026

This Rocket Lab Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday - benzinga.com

Mar 19, 2026

Mar 19, 2026

This Union Pacific Analyst Turns Bullish; Here Are Top 3 Upgrades For Wednesday - Benzinga

Mar 19, 2026

Mar 19, 2026

B Riley Securities initiates coverage of Arcturus Therapeutics Holdings (ARCT) with buy recommendation - MSN

Mar 19, 2026

Mar 19, 2026

Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics By Investing.com - Investing.com Canada

Mar 19, 2026

Mar 18, 2026

Cathie Wood’s ARK sells Guardant Health stock, buys Arcturus Therapeutics - Investing.com

Mar 18, 2026

Mar 18, 2026

Arcturus Therapeutics (NASDAQ:ARCT) Coverage Initiated at B. Riley Financial - MarketBeat

Mar 18, 2026

Mar 18, 2026

This Evommune Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Benzinga

Mar 18, 2026

Mar 18, 2026

ARCT: B. Riley Securities Initiates Coverage with 'Buy' Rating | - GuruFocus

Mar 18, 2026

Mar 17, 2026

Arcturus Therapeutics stresses importance of phased clinical trials in drug development - Traders Union

Mar 17, 2026

Mar 16, 2026

Update Recap: How is Arcturus Therapeutics Holdings Inc managing supply chain issuesWeekly Stock Summary & Short-Term Swing Trade Alerts - baoquankhu1.vn

Mar 16, 2026

Mar 16, 2026

Can Arcturus Therapeutics Holdings Inc sustain its profitabilityMarket Sentiment Review & Reliable Entry Point Alerts - baoquankhu1.vn

Mar 16, 2026

Mar 13, 2026

The Technical Signals Behind (ARCT) That Institutions Follow - Stock Traders Daily

Mar 13, 2026

Mar 12, 2026

Arcturus Therapeutics Teases 12-Week Phase 2 CF Study After Well-Tolerated Inhaled mRNA Dosing - marketbeat.com

Mar 12, 2026

Mar 09, 2026

Patients and scientists join forces for rare disease progress, Arcturus Therapeutics asserts - Traders Union

Mar 09, 2026

Mar 08, 2026

ARCT Should I Buy - Intellectia AI

Mar 08, 2026

Mar 07, 2026

Arcturus (ARCT) Q4 2025 Earnings Call Transcript - AOL.com

Mar 07, 2026

Mar 06, 2026

Stock Report: Can Arcturus Therapeutics Holdings Inc sustain its profitabilityJuly 2025 Fed Impact & AI Powered Buy/Sell Recommendations - baoquankhu1.vn

Mar 06, 2026

Mar 06, 2026

Arcturus Therapeutics: Downgrading to "Hold" As CF Program Shifts Population Focus (ARCT) - Seeking Alpha

Mar 06, 2026

Mar 06, 2026

Arcturus Therapeutics to attend Leerink Partners 2026 Global Healthcare Conference - Traders Union

Mar 06, 2026

Mar 06, 2026

Q1 EPS Forecast for Arcturus Therapeutics Reduced by Analyst - MarketBeat

Mar 06, 2026